These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11583639)

  • 21. Intravenous to Oral Antibiotic Switch Therapy Among Patients Hospitalized With Community-Acquired Pneumonia.
    Deshpande A; Klompas M; Guo N; Imrey PB; Pallotta AM; Higgins T; Haessler S; Zilberberg MD; Lindenauer PK; Rothberg MB
    Clin Infect Dis; 2023 Jul; 77(2):174-185. PubMed ID: 37011018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis.
    Omidvari K; de Boisblanc BP; Karam G; Nelson S; Haponik E; Summer W
    Respir Med; 1998 Aug; 92(8):1032-9. PubMed ID: 9893772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Switch therapy in community-acquired pneumonia.
    Ramirez JA
    Diagn Microbiol Infect Dis; 1995; 22(1-2):219-23. PubMed ID: 7587043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral Antibiotics for Community acquired Pneumonia with Chest indrawing in Children Aged Below Five Years: A Systematic Review.
    Lodha R; Randev S; Kabra SK
    Indian Pediatr; 2016 Jun; 53(6):489-95. PubMed ID: 27376603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia.
    File TM; Rewerska B; Vucinic-Mihailovic V; Gonong JRV; Das AF; Keedy K; Taylor D; Sheets A; Fernandes P; Oldach D; Jamieson BD
    Clin Infect Dis; 2016 Oct; 63(8):1007-1016. PubMed ID: 27448679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment guideline for nursing home-acquired pneumonia based on community practice.
    Naughton BJ; Mylotte JM
    J Am Geriatr Soc; 2000 Jan; 48(1):82-8. PubMed ID: 10642027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of early switch from intravenous to oral antimicrobials in patients with aspiration pneumonia: A prospective observational study.
    Uni M; Nishimura N; Yamano Y; Ishikawa G; Kitamura A; Tomishima Y; Jinta T; Takahashi O; Deshpande G; Chohnabayashi N
    Respir Investig; 2015 Sep; 53(5):225-31. PubMed ID: 26344612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial.
    Hazir T; Fox LM; Nisar YB; Fox MP; Ashraf YP; MacLeod WB; Ramzan A; Maqbool S; Masood T; Hussain W; Murtaza A; Khawar N; Tariq P; Asghar R; Simon JL; Thea DM; Qazi SA;
    Lancet; 2008 Jan; 371(9606):49-56. PubMed ID: 18177775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-hospital observation after antibiotic switch in pneumonia: a national evaluation.
    Nathan RV; Rhew DC; Murray C; Bratzler DW; Houck PM; Weingarten SR
    Am J Med; 2006 Jun; 119(6):512.e1-7. PubMed ID: 16750965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.
    el Moussaoui R; de Borgie CA; van den Broek P; Hustinx WN; Bresser P; van den Berk GE; Poley JW; van den Berg B; Krouwels FH; Bonten MJ; Weenink C; Bossuyt PM; Speelman P; Opmeer BC; Prins JM
    BMJ; 2006 Jun; 332(7554):1355. PubMed ID: 16763247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exclusive oral antibiotic treatment for hospitalized community-acquired pneumonia: a post-hoc analysis of a randomized clinical trial.
    Dinh A; Duran C; Ropers J; Bouchand F; Deconinck L; Matt M; Senard O; Lagrange A; Mellon G; Calin R; Makhloufi S; de Lastours V; Mathieu E; Kahn JE; Rouveix E; Grenet J; Dumoulin J; Chinet T; Pépin M; Delcey V; Diamantis S; Benhamou D; Vitrat V; Dombret MC; Renaud B; Claessens YE; Labarère J; Bedos JP; Aegerter P; Crémieux AC;
    Clin Microbiol Infect; 2024 Aug; 30(8):1020-1028. PubMed ID: 38734138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections.
    Balfour JA; Benfield P
    Pharmacoeconomics; 1996 Aug; 10(2):164-78. PubMed ID: 10163419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia.
    Ailani RK; Agastya G; Ailani RK; Mukunda BN; Shekar R
    Arch Intern Med; 1999 Feb; 159(3):266-70. PubMed ID: 9989538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia.
    Ramirez JA; Srinath L; Ahkee S; Huang A; Raff MJ
    Arch Intern Med; 1995 Jun; 155(12):1273-6. PubMed ID: 7778957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of hospitalization rates in patients with community-acquired pneumonia treated with telithromycin for 5 or 7 days or clarithromycin for 10 days.
    Tellier G; Chang JR; Asche CV; Lavin B; Stewart J; Sullivan SD
    Curr Med Res Opin; 2004 May; 20(5):739-47. PubMed ID: 15140341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of age.
    Lassi ZS; Das JK; Haider SW; Salam RA; Qazi SA; Bhutta ZA
    Arch Dis Child; 2014 Jul; 99(7):687-93. PubMed ID: 24431417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The IMPROVE-GAP Trial aiming to improve evidence-based management of community-acquired pneumonia: study protocol for a stepped-wedge randomised controlled trial.
    Skinner EH; Lloyd M; Janus E; Ong ML; Karahalios A; Haines TP; Kelly AM; Shackell M; Karunajeewa H
    Trials; 2018 Feb; 19(1):88. PubMed ID: 29402313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of an early switch from intravenous to oral antimicrobial therapy for lower respiratory tract infection in patients with severe motor intellectual disabilities.
    Kawamura M; Hoshina T; Ogawa M; Nakamoto T; Kusuhara K
    J Infect Chemother; 2018 Jan; 24(1):40-44. PubMed ID: 29153553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.
    Torres A; Sibila O; Ferrer M; Polverino E; Menendez R; Mensa J; Gabarrús A; Sellarés J; Restrepo MI; Anzueto A; Niederman MS; Agustí C
    JAMA; 2015 Feb; 313(7):677-86. PubMed ID: 25688779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial.
    Blum CA; Nigro N; Briel M; Schuetz P; Ullmer E; Suter-Widmer I; Winzeler B; Bingisser R; Elsaesser H; Drozdov D; Arici B; Urwyler SA; Refardt J; Tarr P; Wirz S; Thomann R; Baumgartner C; Duplain H; Burki D; Zimmerli W; Rodondi N; Mueller B; Christ-Crain M
    Lancet; 2015 Apr; 385(9977):1511-8. PubMed ID: 25608756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.